The financials
Sanofi by the numbers
Sanofi (SNY) reported revenue of €23.7B in H2 2025 (quarter ended December 31, 2025), up 35% from the same quarter a year earlier. That came with a gross margin of 77% and net income of €2.00B (8.4% of revenue). For the full year FY2025, revenue was €43.6B (+6.2% year on year) and net income €7.81B.
| Income statement | H2 2025 | H2 2023 | Change |
|---|---|---|---|
| Revenue | €23.7B | €17.6B | +35% |
| Gross profit | €18.2B | €13.8B | +32% |
| Operating income | €2.58B | €2.64B | −2.0% |
| Net income | €2.00B | €1.98B | +1.1% |
Drug Manufacturers - General
Ranks #9 of 16 by Smart Score